ArticleEuropean thyroid journal2019

Sorafenib and Sunitinib for the Treatment of Metastatic Thyroid Cancer of Follicular Origin: A 7-Year Single-Centre Experience.

Francisco Sousa Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.